MHE State of the Industry survey: Grading the Trump Administration COVID-19 response
In this third of a six-part series, respondents give administration poor marks.
Most of the readers who filled out our State of the Industry survey did so before the November 3 election. A majority (53%) graded the administration’s response to the pandemic as poor (47%) or fair (6%). A sizable minority (42%) deemed it good (20%) or excellent (22%).
The respondents rated the performance of federal government officials. Fifty-two percent of Anthony Fauci’s rankings were in the excellent category. Fauci is the now-famous director of National Institute of Allergy and Infectious Diseases. Twenty-one percent of Alex Azar’s rankings were in the “poor” category. Azar is HHS secretary.
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
